Metraipolis › archive › dc_1e787d13cb33

Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes — Europe PMC PMID:41458542

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41458542
DOI
10.3389/fendo.2025.1749418
License (as archived)
solo-consultazione
Archived
2026-11-07T17:19:03.216Z
SHA-256 of the archived text
e90ca6eea6326fea73454bfce8666eb16cbe9713acf86bfc265635beb627c6fb
Stable URL of this page
https://metraipolis.com/documento/dc_1e787d13cb33

How to cite

Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes — Europe PMC PMID:41458542 — Europe PMC (en), https://europepmc.org/article/MED/41458542 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1e787d13cb33 (Metraipolis archive dc_1e787d13cb33, sha256 e90ca6eea6326fea73454bfce8666eb16cbe9713acf86bfc265635beb627c6fb)
BibTeX
@misc{dc1e787d13cb33,
  title = {Fasting glucagon as an independent risk indicator for CAD in patient with type 2 diabetes — Europe PMC PMID:41458542},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41458542},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1e787d13cb33; sha256 e90ca6eea6326fea73454bfce8666eb16cbe9713acf86bfc265635beb627c6fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41458542. Agents can read the archived copy with the MCP tool read_document.